TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$20.30 MLiabilities$49.35 MCurrent assets$1.03 BNon-current liabilities$29.05 MEquity$1.02 BAssets$1.07 BGross equity(calculated)$1.73 BNon-current assets$42.21 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSMarketable securitiesCash and cash equivalentsPrepaid expenses and other current assetsOperating lease right-of-use assetsProperty and equipment, netRestricted cash, net of current portionOther assetsAccrued expenses and other current liabilitiesOperating lease liabilitiesAccounts payableOperating lease liabilities, net of current portionAdditional paid-in capitalCommon stock, $0.001 par value; 400,000,000 and 200,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively;168,380,091 and 135,940,454 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitAccumulated other comprehensive (loss) incomeAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$15.55 MCurrent liabilitiesCurrent liabilities$20.30 MOperating lease liabilitiesOperating lease liabilities$2.94 MLiabilitiesLiabilities$49.35 MCurrent assetsCurrent assets$1.03 BAccounts payableAccounts payable$1.81 MNon-current liabilitiesNon-current liabilities$29.05 MEquityEquity$1.02 BOperating lease liabilities, net of current portionOperating lease liabilities, net of current portion$29.05 MAssetsAssets$1.07 BGross equity (calculated)Gross equity(calculated)$1.73 BMarketable securitiesMarketable securities$668.43 MCash and cash equivalentsCash and cash equivalents$345.56 MPrepaid expenses and other current assetsPrepaid expenses and other current assets$17.68 MAdditional paid-in capitalAdditional paid-in capital$1.73 BOperating lease right-of-use assetsOperating lease right-of-use assets$33.66 MNon-current assetsNon-current assets$42.21 MProperty and equipment, netProperty and equipment, net$6.09 MRestricted cash, net of current portionRestricted cash, net of current portion$2.14 MOther assetsOther assets$312.00 KCommon stock, $0.001 par value; 400,000,000 and 200,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively;168,380,091 and 135,940,454 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectivelyCommon stock$168.00 KAccumulated deficitAccumulated deficit−$704.01 MAccumulated other comprehensive (loss) incomeAccumulated other comprehensive (loss) income−$633.00 K
Chart details

TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
1,073,880,000 US dollars
Current assets
1,031,671,000 US dollars
Non-current assets
42,209,000 US dollars
Liabilities
49,348,000 US dollars
Current liabilities
20,299,000 US dollars
Non-current liabilities
29,049,000 US dollars
Equity
1,024,532,000 US dollars
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
0 US dollars
Marketable securities
668,432,000 US dollars
Cash and cash equivalents
345,558,000 US dollars
Prepaid expenses and other current assets
17,681,000 US dollars
Restricted cash
0 US dollars
Operating lease right-of-use assets
33,664,000 US dollars
Property and equipment, net
6,094,000 US dollars
Restricted cash, net of current portion
2,139,000 US dollars
Other assets
312,000 US dollars
Accrued expenses and other current liabilities
15,546,000 US dollars
Operating lease liabilities
2,943,000 US dollars
Accounts payable
1,810,000 US dollars
Operating lease liabilities, net of current portion
29,049,000 US dollars
Additional paid-in capital
1,729,004,000 US dollars
Common stock, $0.001 par value; 400,000,000 and 200,000,000 shares authorized at June 30, 2026 and December 31, 2025, respectively;168,380,091 and 135,940,454 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
168,000 US dollars
Accumulated deficit
negative 704,007,000 US dollars
Accumulated other comprehensive (loss) income
negative 633,000 US dollars
Gross equity (calculated)
1,729,172,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus temporary equity plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
TANGO THERAPEUTICS, INC. (TNGX) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!